US FDA Converges With Other Regulators On Insomnia Drug Warnings, But Broader Safety Disagreements Persist
Executive Summary
US FDA will add boxed warnings to insomnia drugs, bringing it in line with other regulators, even as a study in JAMA Internal Medicine study indicates that national drug authorities often disagree more broadly over when to issue safety advisories.